Hairy cell leukemia other diagnostic studies: Difference between revisions
(Created page with "{{Hairy cell leukemia}} {{CMG}} ==Overview== ==References== {{reflist|2}} Category:Disease Category:Types of cancer Category:Hematology Category:Oncology ...") |
|||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
==Bone marrow biopsy== | |||
Most patients require a [[bone marrow biopsy]] for proper diagnosis. The bone marrow biopsy is used to confirm the presence of HCL and also the absence of any secondary disease. Abnormal [[white blood cell]]s bearing hair-like projections from the cytoplasm are seen on [[blood film]] examination or bone marrow biopsy. The diagnosis can be confirmed by viewing the cells with a special stain, known as TRAP, or [[tartrate resistant acid phosphatase]]. | |||
==Flow cytometry== | |||
It is also possible to definitively diagnose hairy cell leukemia through a [[flow cytometry]] blood test which identifies characteristic proteins on the cell surfaces. These cancerous cells are larger than normal and positive for [[CD19]], [[CD20]], [[CD22]], [[CD11c]], [[CD25]], [[CD103]], and [[FMC7]].<ref>{{cite web |url=http://www.flowcases.org/casebuilder/index.cfm?fuseaction=displayCase2&caseID=54 |title=Clinical Flow Cytometry Case #54 |accessdate=2007-09-07 |format= |work=}}</ref> Hairy cell leukemia-variant (HCL-V), which shares some characteristics with B cell prolymphocytic leukemia (B-PLL), does not show CD25 (also called the Interleukin-2 receptor, alpha). As this is relatively new and expensive technology, its adoption by physicians is not uniform, despite the advantages of comfort, simplicity, and safety for the patient when compared to a bone marrow biopsy. | |||
Because a patient could have more than one similar disease, it is also necessary to rule out the presence of leukemias and lymphomas such as [[Splenic marginal zone lymphoma|SMZL]] or [[B-cell prolymphocytic leukemia|B-PLL]]. The presence of these diseases is easily checked during a flow cytometry test, where they characteristically show different results.<ref>{{cite web |url=http://theoncologist.alphamedpress.org/content/vol11/issue7/images/large/780tbl4.jpeg |title=theoncologist.alphamedpress.org |accessdate=2007-09-07 |format= |work=}}</ref> Careful review of bone marrow biopsy samples is also reliable for this purpose. | |||
==References== | ==References== | ||
Revision as of 16:56, 21 January 2012
|
Hairy cell leukemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hairy cell leukemia other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Hairy cell leukemia other diagnostic studies |
|
Risk calculators and risk factors for Hairy cell leukemia other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Bone marrow biopsy
Most patients require a bone marrow biopsy for proper diagnosis. The bone marrow biopsy is used to confirm the presence of HCL and also the absence of any secondary disease. Abnormal white blood cells bearing hair-like projections from the cytoplasm are seen on blood film examination or bone marrow biopsy. The diagnosis can be confirmed by viewing the cells with a special stain, known as TRAP, or tartrate resistant acid phosphatase.
Flow cytometry
It is also possible to definitively diagnose hairy cell leukemia through a flow cytometry blood test which identifies characteristic proteins on the cell surfaces. These cancerous cells are larger than normal and positive for CD19, CD20, CD22, CD11c, CD25, CD103, and FMC7.[1] Hairy cell leukemia-variant (HCL-V), which shares some characteristics with B cell prolymphocytic leukemia (B-PLL), does not show CD25 (also called the Interleukin-2 receptor, alpha). As this is relatively new and expensive technology, its adoption by physicians is not uniform, despite the advantages of comfort, simplicity, and safety for the patient when compared to a bone marrow biopsy.
Because a patient could have more than one similar disease, it is also necessary to rule out the presence of leukemias and lymphomas such as SMZL or B-PLL. The presence of these diseases is easily checked during a flow cytometry test, where they characteristically show different results.[2] Careful review of bone marrow biopsy samples is also reliable for this purpose.
References
- ↑ "Clinical Flow Cytometry Case #54". Retrieved 2007-09-07.
- ↑ "theoncologist.alphamedpress.org". Retrieved 2007-09-07.
